All Stories

  1. Impact of Coumarin Hybrids upon Imperative Clinical Targets against Cancer

    Article • September 2022, Bentham Science Publishers

    ROHIT BHATIA, Aman deep, Dr Ravindra K Rawal

  2. Prospects of Treating Prostate Cancer through Apalutamide: A Mini-Review

    Article • Anti-Cancer Agents in Medicinal Chemistry, April 2022, Bentham Science Publishers

    Dr Ravindra K Rawal, Yunes Al Sayadi, Pooja Chawla

  3. Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy

    Article • Current Molecular Pharmacology, August 2021, Bentham Science Publishers

    ROHIT BHATIA, Dr Ravindra K Rawal, Amit Sharma

  4. Synthetic and Medicinal Perspective of Fused-Thiazoles as Anticancer Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, June 2021, Bentham Science Publishers

    Dr Ravindra K Rawal

  5. Copanlisib: Novel PI3K Inhibitor for the Treatment of Lymphoma

    Article • Anti-Cancer Agents in Medicinal Chemistry, August 2020, Bentham Science Publishers

    Dr Ravindra K Rawal, Pooja Chawla

  6. Isolation of Sinapic Acid from Habenaria intermedia D. Don: A New Chemical Marker for the Identification of Adulteration and Substitution

    Article • Current Traditional Medicine, July 2020, Bentham Science Publishers

    Dr. Vikas Gupta, dr. parveen bansal, Dr Ravindra K Rawal

  7. Genus Calotropis: A Hub of Medicinally Active Phytoconstituents

    Article • Current Traditional Medicine, July 2020, Bentham Science Publishers

    Dr Ravindra K Rawal, dr. parveen bansal

  8. Oxaliplatin for Colorectal Cancer Therapy: A Review

    Article • Clinical Cancer Drugs, November 2018, Bentham Science Publishers

    Dr Ravindra K Rawal, Gaurav Sharma

  9. Natural products and their derivatives as cyclooxygenase-2 inhibitors

    Article • Future Medicinal Chemistry, October 2018, Future Science

    Dr Ravindra K Rawal

  10. RP-HPLC and UV Method Development for Simultaneous Estimation of Doxofylline, Montelukast and Levocetirizine Dihydrochloride in Pharmaceutical Dosages Form

    Article • Analytical Chemistry Letters, March 2018, Taylor & Francis

    Dr Ravindra K Rawal

  11. First report of isolation of maleamic acid from natural source Polygonatum cirrhifolium—A potential chemical marker for identification

    Article • Journal of Liquid Chromatography &amp Related Technologies, December 2017, Taylor & Francis

    Dr. Vikas Gupta, dr. parveen bansal, Dr Ravindra K Rawal

  12. ICP-MS: Analytical Method for Identification and Detection of Elemental Impurities

    Article • Current Drug Discovery Technologies, April 2017, Bentham Science Publishers

    Dr Ravindra K Rawal

  13. Chemical and Medicinal Versatility of Substituted 1,4-Dihydropyridines

    Article • Current Bioactive Compounds, April 2017, Bentham Science Publishers

    Dr Ravindra K Rawal

  14. Synthesis, characterization and pharmacological evaluation of (Z)-2-(5-(biphenyl-4-yl)-3-(1-(imino)ethyl)-2,3-dihydro-1,3,4-oxadiazol-2-yl)phenol derivatives as potent antimicrobial and antioxidant agents

    Article • Arabian Journal of Chemistry, February 2017, Elsevier

    Dr Ravindra K Rawal

  15. Chemistry and Bioactivities of Aristeromycins: An Overview

    Article • Current Topics in Medicinal Chemistry, September 2016, Bentham Science Publishers

    Dr Ravindra K Rawal

  16. Polysaccharides based nanomaterials for targeted anti-cancer drug delivery

    Article • Journal of Drug Targeting, April 2016, Taylor & Francis

    Dr Ravindra K Rawal

  17. Impact of Artificial Neural Networks in QSAR and Computational Modeling

    Article • January 2016, Elsevier

    Dr Ravindra K Rawal

  18. Contributors

    Article • January 2016, Elsevier

    Dr Ravindra K Rawal

  19. Application of RP–HPLC method in dissolution testing and statistical evaluation by NASSAM for simultaneous estimation of tertiary combined dosages forms

    Article • Journal of Pharmaceutical Analysis, October 2015, Elsevier

    Dr Ravindra K Rawal

  20. ChemInform Abstract: Recent Advances in the Chemistry and Biology of Benzothiazoles

    Article • ChemInform, April 2015, Wiley

    Dr Ravindra K Rawal

  21. ChemInform Abstract: Diversity-Oriented Synthesis of Fused-Imidazole Derivatives via Groebke-Blackburn-Bienayme Reaction: A Review

    Article • ChemInform, March 2015, Wiley

    Dr Ravindra K Rawal

  22. Recent Advances in the Chemistry and Biology of Benzothiazoles

    Article • Archiv der Pharmazie, February 2015, Wiley

    Dr Ravindra K Rawal

  23. Diversity-oriented synthesis of fused-imidazole derivatives via Groebke–Blackburn–Bienayme reaction: a review

    Article • Tetrahedron, January 2015, Elsevier

    Dr Ravindra K Rawal

  24. A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

    Article • Anti-Cancer Agents in Medicinal Chemistry, December 2014, Bentham Science Publishers

    Dr Ravindra K Rawal

  25. A Novel Integrase Targeting Agent to Explore the Future Prospective of HIV Eradication: Dolutegravir

    Article • Current HIV Research, November 2014, Bentham Science Publishers

    Dr Ravindra K Rawal

  26. A Comprehensive Review on Combretastatin Analogues as Tubulin Binding Agents

    Article • Current Organic Chemistry, October 2014, Bentham Science Publishers

    Dr Ravindra K Rawal

  27. Riociguat as a treatment regime for pulmonary arterial hypertension: a review

    Article • Clinical and Experimental Hypertension, September 2014, Taylor & Francis

    Dr Ravindra K Rawal

  28. The critical role of bisphosphonates to target bone cancer metastasis: an overview

    Article • Journal of Drug Targeting, September 2014, Taylor & Francis

    Dr Ravindra K Rawal

  29. Chemometrics: A new scenario in herbal drug standardization

    Article • Journal of Pharmaceutical Analysis, August 2014, Elsevier

    Dr Ravindra K Rawal

  30. Chemometrics assisted quantitative estimation of synthetic and marketed formulations

    Article • Asian Journal of Biomedical and Pharmaceutical Sciences, July 2014, Literati Scientific and Publishers, Pvt. Limited

    Dr Ravindra K Rawal

  31. Chemometrics tools used in analytical chemistry: An overview

    Article • Talanta, June 2014, Elsevier

    Dr Ravindra K Rawal

  32. A Compendium of Techniques for the Analysis of Pharmaceutical Impurities

    Article • Current Pharmaceutical Analysis, April 2014, Bentham Science Publishers

    Dr Ravindra K Rawal

  33. Design, synthesis and ex-vivo release studies of colon-specific polyphosphazene–anticancer drug conjugates

    Article • Bioorganic & Medicinal Chemistry, February 2014, Elsevier

    Dr Ravindra K Rawal

  34. Design, synthesis and ex vivo evaluation of colon-specific azo based prodrugs of anticancer agents

    Article • Bioorganic & Medicinal Chemistry Letters, October 2013, Elsevier

    Dr Ravindra K Rawal

  35. Design, Synthesis and In-Vitro Cytotoxicity of Novel Platinum (II) Complexes with Phthalate as the Leaving Group

    Article • Letters in Drug Design & Discovery, September 2013, Bentham Science Publishers

    Dr RAJIV SHARMA, Dr Ravindra K Rawal

  36. Synthesis and Characterization of 3β.-Substituted Amides of 17a-Aza-Dhomo- 4-androsten-17-one as Potent 5.α-Reductase Inhibitors and Antimicrobial Agents

    Article • Current Topics in Medicinal Chemistry, September 2013, Bentham Science Publishers

    Dr Ravindra K Rawal

  37. Simultaneous Estimation and Statistical Evaluation of Developed Validated Methods for Combined Drugs in Marketed Formulation

    Article • Journal of Pharmaceutical Research, March 2013, Krupanidhi Educational Trust

    Dr Ravindra K Rawal

  38. 2′-Fluoro-6′-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: In vitro anti-HBV activity against the lamivudine–entecavir resistant triple mutant and its mechanism of action

    Article • Bioorganic & Medicinal Chemistry Letters, January 2013, Elsevier

    Dr Ravindra K Rawal

  39. Corrigendum to “Antiviral activity of novel 2′-fluoro-6′-methylene-carbocyclic adenosine against wild-type and drug-resistant hepatitis B virus mutants” [Bioorg. Med. Chem. Lett. 21 (2011) 6328–6331]

    Article • Bioorganic & Medicinal Chemistry Letters, April 2012, Elsevier

    Dr Ravindra K Rawal

  40. ChemInform Abstract: Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity

    Article • ChemInform, December 2011, Wiley

    Dr Ravindra K Rawal

  41. Antiviral activity of novel 2′-fluoro-6′-methylene-carbocyclic adenosine against wild-type and drug-resistant hepatitis B virus mutants

    Article • Bioorganic & Medicinal Chemistry Letters, November 2011, Elsevier

    Dr Ravindra K Rawal

  42. ChemInform Abstract: Synthesis and Antiviral Activity of Cyclopropyl-Spirocarbocyclic Adenosine, (4R,5S,6R,7R)-4-(6-Amino-9H-purin-9-yl)-7-(hydroxymethyl)spiro [2.4]heptane-5,6-diol Against Hepatitis C Virus.

    Article • ChemInform, October 2011, Wiley

    Dr Ravindra K Rawal

  43. Recent Advances in Carbocyclic Nucleosides: Synthesis and Biological Activity

    Article • July 2011, Wiley

    Dr Ravindra K Rawal

  44. Synthesis and antiviral activity of cyclopropyl-spirocarbocyclic adenosine, (4R,5S,6R,7R)-4-(6-amino-9H-purin-9-yl)-7-(hydroxymethyl)spiro[2.4]heptane-5,6-diol against hepatitis C virus

    Article • Bioorganic & Medicinal Chemistry Letters, July 2011, Elsevier

    Dr Ravindra K Rawal

  45. ChemInform Abstract: (-)-Carbodine: Enantiomeric Synthesis and in vitro Antiviral Activity Against Various Strains of Influenza Virus Including H5N1 (Avian Influenza) and Novel 2009 H1N1 (Swine Flu).

    Article • ChemInform, September 2010, Wiley

    Dr Ravindra K Rawal

  46. Structure–activity relationships of carbocyclic 6-benzylthioinosine analogues as subversive substrates of Toxoplasma gondii adenosine kinase

    Article • Bioorganic & Medicinal Chemistry, May 2010, Elsevier

    Dr Ravindra K Rawal

  47. (−)-Carbodine: Enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu)

    Article • Bioorganic & Medicinal Chemistry Letters, April 2010, Elsevier

    Dr Ravindra K Rawal

  48. Modified H5 promoter improves stability of insert genes while maintaining immunogenicity during extended passage of genetically engineered MVA vaccines

    Article • Vaccine, February 2010, Elsevier

    Dr. Don J Diamond, Dr Ravindra K Rawal

  49. ChemInform Abstract: Design and Synthesis of 2-(2,6-Dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV Agents.

    Article • ChemInform, April 2009, Wiley

    Dr Ravindra K Rawal

  50. Mamu-A⁎01/Kb transgenic and MHC Class I knockout mice as a tool for HIV vaccine development

    Article • Virology, April 2009, Elsevier

    Dr. Don J Diamond, Dr Ravindra K Rawal

  51. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

    Article • European Journal of Medicinal Chemistry, December 2008, Elsevier

    Dr Ravindra K Rawal

  52. Non-nucleoside inhibitors of the hepatitis C virus NS5B RNA-dependant RNA polymerase: 2-Aryl-3-heteroaryl-1,3-thiazolidin-4-one derivatives

    Article • Bioorganic & Medicinal Chemistry Letters, December 2008, Elsevier

    Dr Ravindra K Rawal

  53. 2-(2,6-Dihalo-phenyl)-3-heteroaryl-2-ylmethyl-1, 3-thiazolidin-4-ones: Anti-HIV agents

    Article • Chemical Biology & Drug Design, August 2008, Wiley

    Dr Ravindra K Rawal

  54. Synthesis and Biological Evaluation of 2, 3-Diaryl substituted-1, 3-thiazolidin-4-ones as Anti-HIV Agents

    Article • Medicinal Chemistry, July 2007, Bentham Science Publishers

    Dr Ravindra K Rawal

  55. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents

    Article • Bioorganic & Medicinal Chemistry, May 2007, Elsevier

    Dr Ravindra K Rawal

  56. Molecular Surface Features in Modeling the HIV-1 RT Inhibitory Activity of 2-(2,6-Disubstituted phenyl)-3-(substituted pyrimidin-2-yl)-thiazolidin-4-ones

    Article • QSAR & Combinatorial Science, March 2007, Wiley

    Dr Ravindra K Rawal

  57. Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents

    Article • Bioorganic & Medicinal Chemistry, February 2007, Elsevier

    Dr Ravindra K Rawal

  58. 2-(2,6-Dichlorophenyl)-3-(quinolin-2-yl)thiazolidin-4-one

    Article • Acta Crystallographica Section E Structure Reports Online, November 2006, International Union of Crystallography

    Dr Ravindra K Rawal

  59. Molecular docking studies on 4-thiazolidinones as HIV-1 RT inhibitors

    Article • Journal of Molecular Modeling, September 2006, Springer Science + Business Media

    Dr Ravindra K Rawal

  60. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT Inhibitors

    Article • Bioorganic & Medicinal Chemistry, December 2005, Elsevier

    Dr Ravindra K Rawal

  61. Synthesis and QSAR Studies on Thiazolidinones as Anti-HIV Agents

    Article • Combinatorial Chemistry & High Throughput Screening, August 2005, Bentham Science Publishers

    Dr Ravindra K Rawal

  62. CP-MLR/PLS Directed Structure-Activity Modeling of the HIV-1 RT Inhibitory Activity of 2,3-Diaryl-1,3-thiazolidin-4-ones

    Article • QSAR & Combinatorial Science, June 2004, Wiley

    Dr Ravindra K Rawal

  63. An expeditious synthesis of thiazolidinones and tetathiazanones

    Article • Journal of Chemical Research, May 2004, Science Reviews 2000 LTD

    Dr Ravindra K Rawal